Alimera Sciences Ret. on equity
What is the Ret. on equity of Alimera Sciences?
The Ret. on equity of Alimera Sciences Inc. is -33.70%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with ret. on equity similar to Alimera Sciences
- Papyrus Australia has Ret. on equity of -33.74%
- Califfi Capital has Ret. on equity of -33.74%
- Novoheart has Ret. on equity of -33.74%
- SECOS has Ret. on equity of -33.73%
- Coziron Resources has Ret. on equity of -33.73%
- Radius Recycling has Ret. on equity of -33.71%
- Alimera Sciences has Ret. on equity of -33.70%
- Purple Biotech has Ret. on equity of -33.70%
- Marinus Pharmaceuticals has Ret. on equity of -33.68%
- Inomin Mines has Ret. on equity of -33.68%
- Yowie has Ret. on equity of -33.64%
- Osprey Gold Development has Ret. on equity of -33.63%
- Revolution Bars Plc has Ret. on equity of -33.63%